• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大环内酯类敏感脓肿分枝杆菌肺病的治疗结果

Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.

作者信息

Choi Hayoung, Jhun Byung Woo, Kim Su-Young, Kim Dae Hun, Lee Hyun, Jeon Kyeongman, Kwon O Jung, Huh Hee Jae, Ki Chang-Seok, Lee Nam Yong, Shin Sung Jae, Daley Charles L, Koh Won-Jung

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

Diagn Microbiol Infect Dis. 2018 Apr;90(4):293-295. doi: 10.1016/j.diagmicrobio.2017.12.008. Epub 2017 Dec 16.

DOI:10.1016/j.diagmicrobio.2017.12.008
PMID:29329759
Abstract

Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15%-20% of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93% (13/14) following antibiotic therapy.

摘要

脓肿分枝杆菌肺病因对大环内酯类药物具有诱导性耐药而难以治疗。然而,15% - 20%的分离株对大环内酯类药物敏感。在14例对大环内酯类药物敏感的脓肿分枝杆菌肺病患者中,所有分离株的erm(41)基因均无功能,抗生素治疗后痰培养转阴率达93%(13/14)。

相似文献

1
Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.大环内酯类敏感脓肿分枝杆菌肺病的治疗结果
Diagn Microbiol Infect Dis. 2018 Apr;90(4):293-295. doi: 10.1016/j.diagmicrobio.2017.12.008. Epub 2017 Dec 16.
2
Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.获得性大环内酯耐药脓肿分枝杆菌肺病患者的临床特征和治疗结局。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01146-17. Print 2017 Oct.
3
Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.采用抗生素成功治疗由脓肿分枝杆菌脓肿亚种引起的肺部疾病,该亚种erm(41)基因第19位发生C到T突变:病例报告
BMC Infect Dis. 2016 May 17;16:207. doi: 10.1186/s12879-016-1554-7.
4
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.肺外脓肿分枝杆菌复合群感染的分枝杆菌学特征及治疗结果
Int J Infect Dis. 2017 Jul;60:49-56. doi: 10.1016/j.ijid.2017.05.007. Epub 2017 May 15.
5
Dissecting (41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus.解析(41)-介导的马红菌素诱导的脓肿分枝杆菌耐药性。
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.01879-19.
6
Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.日本脓肿分枝杆菌复合群感染患者的序列变异与抗生素治疗结果之间的关联。
J Med Microbiol. 2018 Jan;67(1):74-82. doi: 10.1099/jmm.0.000661. Epub 2017 Dec 11.
7
Comparison of drug-susceptibility patterns and gene sequences associated with clarithromycin and azithromycin resistance in complex isolates and evaluation of the accumulation of intrinsic macrolide resistance.复杂分离株中克拉霉素和阿奇霉素耐药相关的药物敏感性模式和基因序列比较,以及固有大环内酯类耐药的累积评估。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001326. Epub 2021 Feb 11.
8
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.阿米卡星雾化吸入作为难治性非结核分枝杆菌肺病的挽救性治疗。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00011-18. Print 2018 Jul.
9
Treatment of Mycobacterium abscessus Pulmonary Disease.脓肿分枝杆菌肺病的治疗
Chest. 2022 Jan;161(1):64-75. doi: 10.1016/j.chest.2021.07.035. Epub 2021 Jul 24.
10
Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance.大环内酯类药物治疗脓肿分枝杆菌和马赛分枝杆菌感染及诱导耐药。
Am J Respir Crit Care Med. 2012 Nov 1;186(9):917-25. doi: 10.1164/rccm.201111-2005OC. Epub 2012 Aug 9.

引用本文的文献

1
Bilateral Jaw Mycobacterium Abscessus Mimicking Actinomycosis: A Postoperative Complication of Wisdom Teeth Extraction.双侧颌骨脓肿分枝杆菌感染酷似放线菌病:智齿拔除术后并发症
Cureus. 2024 Jun 13;16(6):e62336. doi: 10.7759/cureus.62336. eCollection 2024 Jun.
2
Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?卡介苗接种对非结核分枝杆菌感染的保护作用的临床与实验测定:在囊性纤维化中起作用吗?
Vaccines (Basel). 2023 Aug 1;11(8):1313. doi: 10.3390/vaccines11081313.
3
C25-modified rifamycin derivatives with improved activity against .
具有改善的抗……活性的C25修饰利福霉素衍生物。 (原文此处against后内容缺失)
PNAS Nexus. 2022 Aug 9;1(4):pgac130. doi: 10.1093/pnasnexus/pgac130. eCollection 2022 Sep.
4
Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosis.肽酰-tRNA 水解酶是结核分枝杆菌中脯氨酰-tRNA 周转所必需的。
mBio. 2023 Feb 28;14(1):e0346922. doi: 10.1128/mbio.03469-22. Epub 2023 Jan 25.
5
Mycobacterioses Induced by : Case Studies Indicating the Importance of Molecular Analysis for the Identification of Antibiotic Resistance.由……引起的分枝杆菌病:病例研究表明分子分析在鉴定抗生素耐药性中的重要性
Antibiotics (Basel). 2022 Jun 28;11(7):873. doi: 10.3390/antibiotics11070873.
6
Protective Efficacy of BCG Vaccine against and Non-Tuberculous Mycobacterial Infections.卡介苗对结核分枝杆菌和非结核分枝杆菌感染的保护效力
Vaccines (Basel). 2022 Mar 3;10(3):390. doi: 10.3390/vaccines10030390.
7
Management of complex and pulmonary disease: therapeutic advances and emerging treatments.复杂肺部疾病的管理:治疗进展和新疗法。
Eur Respir Rev. 2022 Feb 9;31(163). doi: 10.1183/16000617.0212-2021. Print 2022 Mar 31.
8
Genome reorganization during emergence of host-associated .宿主相关 的出现过程中基因组的重排。
Microb Genom. 2021 Dec;7(12). doi: 10.1099/mgen.0.000706.
9
Impact of Susceptibility to Injectable Antibiotics on the Treatment Outcomes of Pulmonary Disease.对注射用抗生素的敏感性对肺部疾病治疗结果的影响。
Open Forum Infect Dis. 2021 May 12;8(6):ofab215. doi: 10.1093/ofid/ofab215. eCollection 2021 Jun.
10
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.非结核分枝杆菌与脓肿分枝杆菌的崛起。
Nat Rev Microbiol. 2020 Jul;18(7):392-407. doi: 10.1038/s41579-020-0331-1. Epub 2020 Feb 21.